3D Signatures

3D Signatures came to us pre-IPO, needing a consistent brand strategy, an identity and, yes, presentation design before listing.

Their vision was to change the way cancer treatment plans are developed, using genomic imaging to scan telomeres. That last part is the vital piece, and it is also the hard part: a company whose entire thesis rests on something most people have never heard of and cannot picture.

We looked at the whole patient journey, from diagnosis through to treatment, and went looking for the kernel — the reason this company was a game-changer rather than another biotech with a technology.

We found it in the consequence rather than the science. Early diagnosis and targeted treatment save lives and give people a better quality of life, and all of it turns on one tiny piece of our genetic structure.

That became the spine of everything: the identity, the copy, the website and the deck that went in front of investors. Such a tiny telomere needs a beautiful identity and a clear case for support.

3D Signatures listed, and we handled the PR strategy and logistics around the listing itself.

We made sure they rang the bell.